Daratumumab as rescue therapy in life-threatening granulomatosis with polyangiitis
Krusche M, Oqueka T, Wichmann D, Kluge S, Huber T, Kötter I, Schmidt-Lauber C
RHEUMATOLOGY. 2024;63(3):e94-e95.

Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor-T cell therapy
Berger S, Fehse B, Akyüz N, Geffken M, Wolschke C, Janson D, Gagelmann N, Luther M, Wichmann D, Frenzel C, Thayssen G, Alegiani A, Badbaran A, Zeschke S, Dierlamm J, Kröger N, Ayuk F
HAEMATOLOGICA. 2023;108(2):444-456.

Rapid Development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway
Brakert L, Berneking L, Both A, Berinson B, Huang J, Aepfelbacher M, Wolschke C, Wichmann D, Rohde H
J GLOB ANTIMICROB RE. 2023;34:59-62.

Comparative analysis of characteristics and outcomes in hospitalized COVID-19 patients infected with different SARS-CoV-2 variants between January 2020 and April 2022 - A retrospective single-center cohort study
Brehm T, Heyer A, Woo M, Fischer M, van der Meirschen M, Wichmann D, Jarczak D, Roedl K, Schmiedel S, Addo M, Lütgehetmann M, Christner M, Huber S, Lohse A, Kluge S, Schulze Zur Wiesch J
J INFECT PUBLIC HEAL. 2023;16(11):1806-1812.

Clinical pharmacy services in critical care: results of an observational study comparing ward-based with remote pharmacy services
Hilgarth H, Wichmann D, Baehr M, Kluge S, Langebrake C
INT J CLIN PHARM-NET. 2023;45(4):847-856.

Posaconazole exposure in critically ill ICU patients: a need for action
König C, Göpfert M, Kluge S, Wichmann D
INFECTION. 2023;51(6):1767-1772.

Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation
Roedl K, De Rosa S, Fischer M, Braunsteiner J, Schmidt-Lauber C, Jarczak D, Huber T, Kluge S, Wichmann D
ANN INTENSIVE CARE. 2023;13(1):115.

Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?
Sensen B, Wichmann D, Kluge S
PNEUMOLOGIE. 2023;77(1):21-26.

Sotrovimab in Hospitalized Patients with SARS-CoV-2 Omicron Variant Infection: a Propensity Score-Matched Retrospective Cohort Study
Woo M, Brehm T, Fischer M, Heyer A, Wichmann D, Jordan S, Nörz D, Lütgehetmann M, Addo M, Lohse A, Schmiedel S, Kluge S, Schulze Zur Wiesch J
MICROBIOL SPECTR. 2023;11(1):.

Outcomes of critically ill coronavirus disease 2019 patients requiring kidney replacement therapy: A retrospective cohort study
Braunsteiner J, Kluge S, Schmidt-Lauber C, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Hoxha E, Huber T, Wichmann D, Kluge S, Fischer M, Roedl K
FRONT MED-LAUSANNE. 2022;9:.

Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants
Brehm T, Pfefferle S, von Possel R, Karolyi M, Zoufaly A, Wichmann D, Kobbe R, Emmerich P, Nörz D, Aepfelbacher M, Schulze Zur Wiesch J, Addo M, Schmiedel S, Lütgehetmann M
J MED VIROL. 2022;94(10):5038-5043.

New Insights in the Occurrence of Venous Thromboembolism in Critically Ill Patients with COVID-19 - A Large Postmortem and Clinical Analysis
Heinrich F, Roedl K, Jarczak D, Goebels H, Heinemann A, Schäfer U, Ludwig F, Bachmann M, Bein B, Weber C, Sydow K, Bota M, Paschen H, Weerth A, Veit C, Detsch O, Brand P, Kluge S, Ondruschka B, Wichmann D
VIRUSES-BASEL. 2022;14(4):.

The Prevalence of Early‐ and Late‐Onset Bacterial, Viral and Fungal Respiratory Superinfections in Invasively Ventilated COVID‐19 Patients.
Paparoupa M, Aldemyati R, Roggenkamp H, Berinson B, Nörz D, Olearo F, Kluge S, Roedl K, Heer G, Wichmann D
J MED VIROL. 2022;94(5):1920-1925.

The effects of SARS-CoV-2 virus type and of vaccination status on causes of death over the course of the COVID-19 pandemic
Paparoupa M, Schröder A, Braunsteiner J, Addo M, Lütgehetmann M, Roedl K, Kluge S, Ondruschka B, Wichmann D
DTSCH ARZTEBL INT. 2022;119(35-36):607-608.

Chronic Critical Illness in Patients with COVID-19: Characteristics and Outcome of Prolonged Intensive Care Therapy
Roedl K, Jarczak D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Kluge S, Wichmann D
J CLIN MED. 2022;11(4):.

Comparison of four diagnostic criteria for invasive pulmonary aspergillosis - a diagnostic accuracy study in critically ill patients
Schroeder M, Giese M, Wijaya C, Winterland S, Nuechtern A, Grensemann J, Matthews H, Wichmann D, Stamm J, Rohde H, Christner M, Ozga A, Steurer S, Heinemann A, Simon M, Fischer M, Kluge S
MYCOSES. 2022;65(8):824-833.

Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?
Sensen B, Wichmann D, Kluge S
DEUT MED WOCHENSCHR. 2022;147(20):1313-1320.

Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factors
Voigtlaender M, Edler C, Gerling M, Schädler J, Ondruschka B, Schröder A, Sperhake J, Ehrhardt S, Wang L, Haddad M, Kiencke V, Renné T, Roedl K, Kluge S, Wichmann D, Langer F
THROMB RES. 2022;218:171-176.

Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting
Ayuk F, Berger C, Badbaran A, Zabelina T, Sonntag T, Riecken K, Geffken M, Wichmann D, Frenzel C, Thayssen G, Zeschke S, Kröger N, Fehse B
BLOOD ADV. 2021;5(11):2523-2527.

Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza
Brehm T, van der Meirschen M, Hennigs A, Roedl K, Jarczak D, Wichmann D, Frings D, Nierhaus A, Oqueka T, Fiedler W, Christopeit M, Kraef C, Schultze A, Lütgehetmann M, Addo M, Schmiedel S, Kluge S, Schulze Zur Wiesch J
SCI REP-UK. 2021;11(1):.

Scabies crustosa in a recipient of an allogeneic stem cell transplantation
Christopeit M, Wichmann D
INFECTION. 2021;49(2):375-376.

Erratum zu: Toxizitäten nach Chimärer-Antigenrezeptor-T-Zell-Therapie
Garcia Borrega J, Heindel K, Göreci Y, Warnke C, Onur O, Kochanek M, Schub N, Ayuk F, Wichmann D, Böll B
INTERNIST. 2021;62(6):694.

Toxizitäten nach Chimärer-Antigenrezeptor-T-Zell-Therapie : Übersicht und Management früher und verzögerter Nebenwirkungen
Garcia Borrega J, Heindel K, Göreci Y, Warnke C, Onur O, Kochanek M, Schub N, Ayuk F, Wichmann D, Böll B
INTERNIST. 2021;62(6):611-619.

SARS-CoV-2 Blood RNA Load Predicts Outcome in Critically Ill COVID-19 Patients
Heinrich F, Nentwich M, Bibiza-Freiwald E, Nörz D, Roedl K, Christner M, Hoffmann A, Olearo F, Kluge S, Aepfelbacher M, Wichmann D, Lütgehetmann M, Pfefferle S
OPEN FORUM INFECT DI. 2021;8(11):.

Hepatic vasculopathy and regenerative responses of the liver in fatal cases of COVID-19
Kaltschmidt B, Fitzek A, Schaedler J, Förster C, Kaltschmidt C, Hansen T, Steinfurth F, Windmöller B, Pilger C, Kong C, Singh K, Nierhaus A, Wichmann D, Sperhake J, Püschel K, Huser T, Krüger M, Robson S, Wilkens L, Schulte Am Esch J
CLIN GASTROENTEROL H. 2021;19(8):1726-1729.e3.

Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
König C, Both A, Rohde H, Kluge S, Frey O, Röhr A, Wichmann D
ANTIBIOTICS-BASEL. 2021;10(6):649.

Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
König C, Both A, Rohde H, Kluge S, Frey O, Röhr A, Wichmann D
ANTIBIOTICS-BASEL. 2021;10(10):.

Leitlinie: Diagnostik und Therapie der Malaria: AWMF Register-Nr. 042-001
Kreuels B, Bissinger A, Boecken G, Burchard G, Feldt T, Grobusch M, Jochum J, Kroidl I, Löbermann M, Löscher T, Rothe C, Schmiedel S, Schneitler S, Steiner F, Stich A, Stojkovic M, Wiemer D, Belard S, Kurth F, Tannich E, Kobbe R, Wichmann D, Ramharter M
2021.

Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR
Olearo F, Nörz D, Heinrich F, Sutter J, Roedl K, Schultze A, Wiesch J, Braun P, Oestereich L, Kreuels B, Wichmann D, Aepfelbacher M, Pfefferle S, Lütgehetmann M
J CLIN VIROL. 2021;137:.

Viral Dynamics of SARS-CoV-2 in Critically Ill Allogeneic Hematopoietic Stem Cell Transplant Recipients and Immunocompetent Patients with COVID-19
Roedl K, Heidenreich S, Pfefferle S, Jarczak D, Urbanowicz T, Nörz D, Aepfelbacher M, Kröger N, Kluge S, Lütgehetmann M, Christopeit M, Wichmann D
AM J RESP CRIT CARE. 2021;203(2):242-245.

Severe liver dysfunction complicating course of COVID-19 in the critically ill: multifactorial cause or direct viral effect?
Roedl K, Jarczak D, Drolz A, Wichmann D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Lütgehetmann M, Kluge S, Fuhrmann V
ANN INTENSIVE CARE. 2021;11(1):.

Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation—A Retrospective Cohort Study
Roedl K, Kahn A, Jarczak D, Fischer M, Boenisch O, Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Braune S, Yildirim Y, Bernhardt A, Reichenspurner H, Kluge S, Wichmann D
J CLIN MED. 2021;10(22):.

Characteristics and Risk Factors for Intensive Care Unit Cardiac Arrest in Critically Ill Patients with COVID-19—A Retrospective Study
Roedl K, Söffker G, Wichmann D, Boenisch O, de Heer G, Burdelski C, Frings D, Sensen B, Nierhaus A, Westermann D, Kluge S, Jarczak D
J CLIN MED. 2021;10(10):.

Sepsis und septischer Schock
Rolling T, Wichmann D
2021. Klinikleitfaden Infektiologie. Jung N, Rieg S, Lehmann C (eds.). 1. ed. München: Urban & Fischer, 142-144.

Therapie bei COVID-19: Das bisher Erreichte
Wichmann D
wmw skriptum. 2021;18(07):16-18.

Rätselhafte B-Symptomatik bei einem 61-Jährigen unter Therapie einer rheumatoiden Arthritis
Wüstenberg R, Christner M, Schmiedel S, Tariparast A, Wichmann D, Lennartz M, Klose H, Kluge S
INTERNIST. 2021;62(11):1231-1236.

Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol
Zimmer J, Röhr A, Kluge S, Faller J, Frey O, Wichmann D, König C
ANTIBIOTICS-BASEL. 2021;10(3):242.

SARS-CoV-2 renal tropism associates with acute kidney injury
Braun F, Lütgehetmann M, Pfefferle S, Wong M, Carsten A, Lindenmeyer M, Nörz D, Heinrich F, Meißner K, Wichmann D, Kluge S, Gross O, Pueschel K, Schröder A, Edler C, Aepfelbacher M, Puelles V, Huber T
LANCET. 2020;396(10251):597-598.

Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients
Ghandili S, Pfefferle S, Roedl K, Sonnemann P, Karagiannis P, Boenisch O, Kluge S, Schmiedel S, Ittrich H, Rohde H, Lütgehetmann M, Weisel K, Bokemeyer C, Wichmann D, Fiedler W, Jarczak D, Modemann F
BLOOD ADV. 2020;4(23):5936-5941.

Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
Karagiannis P, Sänger L, Alsdorf W, Weisel K, Fiedler W, Kluge S, Wichmann D, Bokemeyer C, Fuhrmann V
CANCERS. 2020;12(6):.

Pushing beyond specifications:Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommendations
Nörz D, Frontzek A, Eigner U, Oestereich L, Wichmann D, Kluge S, Fischer N, Aepfelbacher M, Pfefferle S, Lütgehetmann M
J CLIN VIROL. 2020;132:104650.

Operational framework and training standard requirements for AI-empowered robotic surgery
O'Sullivan S, Leonard S, Holzinger A, Allen C, Battaglia F, Nevejans N, van Leeuwen F, Sajid M, Friebe M, Ashrafian H, Heinsen H, Wichmann D, Hartnett M, Gallagher A
INT J MED ROBOT COMP. 2020;16(5):1-13.

Multiorgan and Renal Tropism of SARS-CoV-2
Puelles V, Lütgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, Braun F, Lu S, Pfefferle S, Schröder A, Edler C, Gross O, Glatzel M, Wichmann D, Wiech T, Kluge S, Pueschel K, Aepfelbacher M, Huber T
NEW ENGL J MED. 2020;383(6):590-592.

Intensivmedizin und COVID-19
Roedl K, Kluge S, Wichmann D
Klinikarzt. 2020;2020(49):409-413.

Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis
Schroeder M, Weber T, Denker T, Winterland S, Wichmann D, Rohde H, Ozga A, Fischer M, Kluge S
ANN INTENSIVE CARE. 2020;10(1):142.

Malaria
Wichmann D
2020. Referenz Intensivmedizin. Marx G, Zacharowski K, Kluge S (eds.). Georg Thieme Verlag KG Stuttgart · New York, 753-758.

Response: Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Wichmann D
ANN INTERN MED. 2020;173(12):1030.

Intensivmedizinisches Back-up bei infektiologischen Katastrophen
Wichmann D, Matthews H, Nentwich M, Schmiedel S, Kluge S
MED KLIN-INTENSIVMED. 2020;115(8):641-648.

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study
Wichmann D, Sperhake J, Lütgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schröder A, Burdelski C, de Heer G, Nierhaus A, Frings D, Pfefferle S, Becker H, Bredereke-Wiedling H, de Weerth A, Paschen H, Sheikhzadeh-Eggers S, Stang A, Schmiedel S, Bokemeyer C, Addo M, Aepfelbacher M, Püschel K, Kluge S
ANN INTERN MED. 2020;173(4):268-277.

In vitro removal of anti-infective agents by a novel cytokine adsorbent system
König C, Röhr A, Frey O, Brinkmann A, Roberts J, Wichmann D, Braune S, Kluge S, Nierhaus A
INT J ARTIF ORGANS. 2019;42(2):57-64.

Management der saisonalen Influenza 2017/2018: Erfahrungen an einem deutschen Universitätsklinikum
Kraef C, van der Meirschen M, Wichmann D, Kutza M, Restemeyer C, Addo M, Lohse A, Schmiedel S, Kluge S, Schulze Zur Wiesch J
BUNDESGESUNDHEITSBLA. 2019;62(7):870-880.

Invasive pulmonale Aspergillose
Matthews H, Rohde H, Wichmann D, Kluge S
DEUT MED WOCHENSCHR. 2019;144(17):1218-1222.

Low-flow CO removal in combination with renal replacement therapy effectively reduces ventilation requirements in hypercapnic patients: a pilot study
Nentwich J, Wichmann D, Kluge S, Lindau S, Mutlak H, John S
ANN INTENSIVE CARE. 2019;9(1):3.

Invasive Aspergillose bei Influenza? Zufall oder Bestimmung?
Matthews H, Boenisch O, Wichmann D, Schroeder M, Kluge S
Intensiv News. 2018;22(6):5-8.

Virtual autopsy: Machine Learning and AI provide new opportunities for investigating minimal tumor burden and therapy resistance by cancer patients
O'Sullivan S, Holzinger A, Wichmann D, Saldiva P, Sajid M, Zatloukal K
Autopsy & Case Reports. 2018;8(1):e2018003.

Virtual autopsy and community engagement for outbreak response in Africa: traditional, religious and sociocultural perspectives
O'Sullivan S, Sajid M, Agusto F, Mwangangi J, Manguvo A, Wichmann D, Kharoshah M
EGYPT J FORENSIC SCI. 2018;8(1):67.

Hantavirale Erkrankungen
Wichmann D
Arzneiverordnung in der Praxis. 2018;45(1):29-32.

Efficacy of introducing a checklist to reduce central venous line associated bloodstream infections in the ICU caring for adult patients
Wichmann D, Belmar Campos C, Ehrhardt S, Kock T, Weber C, Rohde H, Kluge S
BMC INFECT DIS. 2018;18(1):267.

Prospective study of device-related complications in intensive care unit detected by virtual autopsy
Wichmann D, Heinemann A, Zähler S, Vogel H, Höpker W, Püschel K, Kluge S
BRIT J ANAESTH. 2018;120(6):1229-1236.

Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate
Both A, Büttner H, Huang J, Perbandt M, Belmar Campos C, Christner M, Maurer F, Kluge S, König C, Aepfelbacher M, Wichmann D, Rohde H
J ANTIMICROB CHEMOTH. 2017;72(9):2483-2488.

Risk factors for excessively prolonged meropenem use in the intensive care settinga case-contol study
Katchanov J, Kreuels B, Maurer F, Wöstmann K, Jochum J, König C, Seoudy K, Rohde H, Lohse A, Wichmann D, Baehr M, Rothe C, Kluge S
BMC INFECT DIS. 2017;17(1):131.

Machine learning enhanced virtual autopsy
O'Sullivan S, Holzinger A, Zatloukal K, Saldiva P, Sajid M, Wichmann D
Autopsy & Case Reports. 2017;7(4):3-7.

Medizinische Probleme in der Höhe und Höhenkrankheit
Wichmann D
SPORTS Skimanual 2017/2018. 2017.

Intensivmedizinische Behandlung eines Patienten mit Ebola-Virusinfektion in Deutschland
Wichmann D, Kreuels B, Schmiedel S, Kluge S
MED KLIN-INTENSIVMED. 2017;112(1):38-41.

Unique human immune signature of Ebola virus disease in Guinea
Ruibal P, Oestereich L, Lüdtke A, Becker-Ziaja B, Wozniak D, Kerber R, Korva M, Cabeza-Cabrerizo M, Bore J, Koundouno F, Duraffour S, Weller R, Thorenz A, Cimini E, Viola D, Agrati C, Repits J, Afrough B, Cowley L, Ngabo D, Hinzmann J, Mertens M, Vitoriano I, Logue C, Boettcher J, Pallasch E, Sachse A, Bah A, Nitzsche K, Kuisma E, Michel J, Holm T, Zekeng E, García-Dorival I, Wölfel R, Stoecker K, Fleischmann E, Strecker T, Di Caro A, Avšič-Županc T, Kurth A, Meschi S, Mély S, Newman E, Bocquin A, Kis Z, Kelterbaum A, Molkenthin P, Carletti F, Portmann J, Wolff S, Castilletti C, Schudt G, Fizet A, Ottowell L, Herker E, Jacobs T, Kretschmer B, Severi E, Ouedraogo N, Lago M, Negredo A, Franco L, Anda P, Schmiedel S, Kreuels B, Wichmann D, Addo M, Lohse A, De Clerck H, Nanclares C, Jonckheere S, Van Herp M, Sprecher A, Xiaojiang G, Carrington M, Miranda O, Castro C, Gabriel M, Drury P, Formenty P, Diallo B, Koivogui L, Magassouba N, Carroll M, Günther S, Muñoz-Fontela C
NATURE. 2016;533(7601):100-4.

Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? - A prospective observational study
Schroeder M, Simon M, Katchanov J, Wijaya C, Rohde H, Christner M, Laqmani A, Wichmann D, Fuhrmann V, Kluge S
CRIT CARE. 2016;20(1):139.

Diagnostik der Schistosomiasis (Bilharziose) – Notwendige Untersuchungen bei Reiserückkehrern und Patienten aus Endemiegebieten
Wichmann D
FLUGMEDIZIN TROPENME. 2015;22(2):73-77.

Isolation in patients with Ebola virus disease
Wichmann D, Schmiedel S, Kluge S
INTENS CARE MED. 2015;41(3):511-3.

Diagnosis of neuroschistosomiasis by antibody specificity index and semi-quantitative real-time PCR from cerebrospinal fluid and serum
Härter G, Frickmann H, Zenk S, Wichmann D, Ammann B, Kern P, Fleischer B, Tannich E, Poppert S
J MED MICROBIOL. 2014;63(Pt 2):309-12.

A case of severe Ebola virus infection complicated by gram-negative septicemia
Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, Heer G, Kluge S, Sow A, Renné T, Günther S, Lohse A, Addo M, Schmiedel S
NEW ENGL J MED. 2014;371(25):2394-401.

Standard-pO2 zur Unterscheidung von primärer und sekundärer Hypoxämie. Erwiderung
Wichmann D, Baumann H, Kluge S
MED KLIN-INTENSIVMED. 2014;109(1):64-5.

A plea for autopsy in the modern ICU
Wichmann D, Braune S, Kluge S
CRIT CARE MED. 2014;42(8):e595.

Virtual autopsy with multiphase postmortem computed tomographic angiography versus traditional medical autopsy to investigate unexpected deaths of hospitalized patients: a cohort study
Wichmann D, Heinemann A, Weinberg C, Vogel H, Hoepker W, Grabherr S, Püschel K, Kluge S
ANN INTERN MED. 2014;160(8):534-41.

Safety of percutaneous dilatational tracheostomy in patients on extracorporeal lung support
Braune S, Kienast S, Hadem J, Wiesner O, Wichmann D, Nierhaus A, Simon M, Welte T, Kluge S
INTENS CARE MED. 2013;39(10):1792-9.

Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome
Braune S, Wichmann D, Heinz M, Nierhaus A, Becker H, Meyer T, Meyer G, Müller-Schulz M, Fricke J, de Weerth A, Höpker W, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl R, Wegscheider K, Kluge S
CRIT CARE MED. 2013;41(7):1702-10.

Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis--a prospective, observational study
Nierhaus A, Klatte S, Linssen J, Eismann N, Wichmann D, Hedke J, Braune S, Kluge S
BMC IMMUNOL. 2013;14:8.

Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis
Rolling T, Wichmann D, Schmiedel S, Burchard G, Kluge S, Cramer J
MALARIA J. 2013;12:241.

Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis
Soeffker G, Wichmann D, Loderstädt U, Sobottka I, Deuse T, Kluge S
PROG TRANSPLANT. 2013;23(1):71-4.

Langzeitadaptation an chronische Hypoxämie. Klinische Präsentation
Wichmann D, Baumann H, Kluge S
MED KLIN-INTENSIVMED. 2013;108(4):323-4.

Invasive pulmonary aspergillosis in the ICU:an emerging disease?
Wichmann D, Kluge S
INTENS CARE MED. 2013;39(4):790.

Prospective European-wide multicentre study on a blood based real-time PCR for the diagnosis of acute schistosomiasis
Wichmann D, Poppert S, Von Thien H, Clerinx J, Dieckmann S, Jensenius M, Parola P, Richter J, Schunk M, Stich A, Zanger P, Burchard G, Tannich E
BMC INFECT DIS. 2013;13:55.

Moderne Leichenschau
Heinemann A, Seifert D, Denzer U, Rösch T, Lorenzen M, Adam G, Wichmann D, Kluge S, Vogel H, Sauter G, Püschel K
Hamb Ärztebl. 2012;66(06/07):12-17.

Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin.
Kluge S, Braune S, Nierhaus A, Wichmann D, Derlin T, Mester J, Klutmann S
J CRIT CARE. 2012;27(3):1-7.

Use of a weighted, automated analysis of the differential blood count to differentiate sepsis from non-infectious systemic inflammation: the intensive care infection score (ICIS).
Nierhaus A, Linssen J, Wichmann D, Braune S, Kluge S
INFLAMM ALLERGY DRUG TARGETS. 2012;11(2):109-115.

Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.
Rolling T, Schmiedel S, Wichmann D, Wittkopf D, Burchard G, Cramer J
MALARIA J. 2012;11:169.

Candida im Respirationstrakt: No longer an innocent bystander?
Wichmann D, Kluge S
Intensiv News. 2012.

Virtual autopsy as an alternative to traditional medical autopsy in the intensive care unit: a prospective cohort study.
Wichmann D, Obbelode F, Vogel H, Hoepker W, Nierhaus A, Braune S, Sauter G, Püschel K, Kluge S
ANN INTERN MED. 2012;156(2):123-130.

Acute schistosomiasis in a cluster of travelers from Rwanda: diagnostic contribution of schistosome DNA detection in serum compared to parasitology and serology.
Clerinx J, Bottieau E, Wichmann D, Tannich E, Marjan V
J TRAVEL MED. 2011;18(6):367-372.

Der besondere Fall · Suizidversuch mit Knollenblätterpilz
Harlandt O, Wichmann D, de Heer G, Fischer L, Nashan B, Reimer J, Benten D, Lohse A, Kluge S
Hamb Ärztebl. 2011;65(5):34-35.

Lebensmüde ernten ihr Gift neuerdings im Wald ... Suizidversuch mit Knollenblätterpilz
Harlandt O, Wichmann D, de Heer G, Fischer L, Nashan B, Reimer J, Benten D, Lohse A, Kluge S
Medical Tribune. 2011;43(40):7.

Reduced cardiac output in imported Plasmodium falciparum malaria.
Herr J, Mehrfahr P, Schmiedel S, Wichmann D, Brattig N, Burchard G, Cramer J
MALARIA J. 2011;10:160.

Genomic Tandem Repeat Analysis Proves Laboratory-Acquired Brucellosis in Veterinary (Camel) Diagnostic Laboratory in the United Arab Emirates.
Schulze Zur Wiesch J, Wichmann D, Sobottka I, Rohde H, Schmoock G, Wernery R, Schmiedel S, Burchard G, Melzer F
ZOONOSES PUBLIC HLTH. 2010;57(5):315-317.

No evidence of chikungunya virus and antibodies shortly before the outbreak on Sri Lanka.
Panning M, Wichmann D, Grywna K, Annan A, Wijesinghe S, Kularatne S, Drosten C
MED MICROBIOL IMMUN. 2009;198(2):103-106.

CARDIAC INVOLVEMENT IN DENGUE VIRUS INFECTIONS DURING THE 2004/2005 DENGUE FEVER SEASON IN SRI LANKA
Wichmann D, Kularatne S, Ehrhardt S, Wijesinghe S, Brattig N, Abel W, Burchard G
SEA J Trop Med Pub H. 2009;40(4):727-730.

Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma.
Wichmann D, Panning M, Quack T, Kramme S, Burchard G, Grevelding C, Drosten C
PLOS NEGLECT TROP D. 2009;3(4):422.

Primary HIV infection presenting as haemolytic crisis in a patient with previously undiagnosed glucose 6-phosphate dehydrogenase deficiency.
Schulze Zur Wiesch J, Wichmann D, Hennigs A, van Lunzen J, Burchard G, Schmiedel S
AIDS. 2008;22(14):1886-1888.

Glycosylphosphatidylinositol-induced cardiac myocyte death might contribute to the fatal outcome of Plasmodium falciparum malaria.
Wennicke K, Debierre-Grockiego F, Wichmann D, Brattig N, Pankuweit S, Maisch B, Schwarz R, Ruppert V
APOPTOSIS. 2008;13(7):857-866.

If the rumor is tumor, the issue is tissue.
Wichmann D, Scherpe S, Heese O, Schmiedel S, Burchard G, Ruckdeschel K, Sobottka I
NEUROSURGERY. 2008;63(4):820.

Plasmodium falciparum glycosylphosphatidylinositol induces limited apoptosis in liver and spleen mouse tissue.
Wichmann D, Schwarz R, Ruppert V, Ehrhardt S, Cramer J, Burchard G, Maisch B, Debierre-Grockiego F
APOPTOSIS. 2007;12(6):1037-1041.

Myeloradiculitis: a rare event in schistosoma infection.
Wichmann D, Hofmann C, Sudeck H, Burchard G, Moser A
INFECTION. 2006;34(6):349-351.

High levels of circulating cardiac proteins indicate cardiac impairment in African children with severe Plasmodium falciparum malaria.
Ehrhardt S, Mockenhaupt F, Anemana S, Otchwemah R, Wichmann D, Cramer J, Bienzle U, Burchard G, Brattig N
MICROBES INFECT. 2005;7(11-12):1204-1210.

Circulating concentrations of cardiac proteins in complicated and uncomplicated Plasmodium falciparum malaria.
Ehrhardt S, Wichmann D, Hemmer C, Burchard G, Brattig N
TROP MED INT HEALTH. 2004;9(10):1099-1103.

Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice.
Wichmann D, Gröne H, Frese M, Pavlovic J, Anheier B, Haller O, Klenk H, Feldmann H
J VIROL. 2002;76(17):8890-8899.

Hemorrhagic fever with renal syndrome: diagnostic problems with a known disease.
Wichmann D, Slenczka W, Alter P, Boehm S, Feldmann H
J CLIN MICROBIOL. 2001;39(9):3414-3416.

Lack of evidence for an association between hantavirus infections and Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and giant cell arteritis.
Gerke P, Wichmann D, Schönermarck U, Schütt M, Feldmann H, Ksiazek T, Rob P, Gross W
RHEUMATOLOGY. 2000;39(12):1424-1425.

Letzte Aktualisierung aus dem FIS: 24.04.2024 - 05:01 Uhr